EP1513505A4 - An improved modified release preparation - Google Patents

An improved modified release preparation

Info

Publication number
EP1513505A4
EP1513505A4 EP03709444A EP03709444A EP1513505A4 EP 1513505 A4 EP1513505 A4 EP 1513505A4 EP 03709444 A EP03709444 A EP 03709444A EP 03709444 A EP03709444 A EP 03709444A EP 1513505 A4 EP1513505 A4 EP 1513505A4
Authority
EP
European Patent Office
Prior art keywords
modified release
release preparation
improved modified
improved
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP03709444A
Other languages
German (de)
French (fr)
Other versions
EP1513505A1 (en
Inventor
David Hayes
Angelo Lepore
Stefan Lukas
Eugene Anthony Quinn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayne Pharma International Pty Ltd
Original Assignee
Mayne Pharma International Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayne Pharma International Pty Ltd filed Critical Mayne Pharma International Pty Ltd
Publication of EP1513505A1 publication Critical patent/EP1513505A1/en
Publication of EP1513505A4 publication Critical patent/EP1513505A4/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP03709444A 2002-04-12 2003-04-11 An improved modified release preparation Ceased EP1513505A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPS1676A AUPS167602A0 (en) 2002-04-12 2002-04-12 An improved modified release preparation
AUPS167602 2002-04-12
PCT/AU2003/000434 WO2003086366A1 (en) 2002-04-12 2003-04-11 An improved modified release preparation

Publications (2)

Publication Number Publication Date
EP1513505A1 EP1513505A1 (en) 2005-03-16
EP1513505A4 true EP1513505A4 (en) 2011-02-16

Family

ID=3835253

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03709444A Ceased EP1513505A4 (en) 2002-04-12 2003-04-11 An improved modified release preparation

Country Status (7)

Country Link
EP (1) EP1513505A4 (en)
JP (1) JP2005528388A (en)
AU (1) AUPS167602A0 (en)
CA (1) CA2480783C (en)
NO (1) NO20044463L (en)
NZ (1) NZ535372A (en)
WO (1) WO2003086366A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1768668A2 (en) 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
PE20091620A1 (en) 2008-03-11 2009-11-12 Takeda Pharmaceutical SOLID ORAL DISINTEGRATION PREPARATION
AR083651A1 (en) 2010-10-21 2013-03-13 Galderma Sa BRIMONIDINE COMPOSITIONS IN GEL AND METHODS OF USE
RU2013123055A (en) * 2010-10-21 2014-11-27 Галдерма С.А. LONG-TERM TABLET AND METHOD FOR PRODUCING IT
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
CN102579408B (en) * 2012-03-19 2013-06-05 河南中帅医药科技发展有限公司 Doxycycline hydrochloride dual-release preparation and preparation method thereof
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0418565A2 (en) * 1989-09-21 1991-03-27 American Cyanamid Company Pulsatile once-a-day delivery system for minocycline
EP0470047A1 (en) * 1990-07-27 1992-02-05 Warner-Lambert Company Sustained release formulations
WO1994002140A1 (en) * 1992-07-17 1994-02-03 Astra Aktiebolag Pharmaceutical composition containing antiulcer agent
WO2003075852A2 (en) * 2002-03-07 2003-09-18 Advancis Pharmaceuticals Corporation Antibiotic composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
SI9700186B (en) * 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Novel pharmaceutical preparation with controlled release of active healing substances

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0418565A2 (en) * 1989-09-21 1991-03-27 American Cyanamid Company Pulsatile once-a-day delivery system for minocycline
EP0470047A1 (en) * 1990-07-27 1992-02-05 Warner-Lambert Company Sustained release formulations
WO1994002140A1 (en) * 1992-07-17 1994-02-03 Astra Aktiebolag Pharmaceutical composition containing antiulcer agent
WO2003075852A2 (en) * 2002-03-07 2003-09-18 Advancis Pharmaceuticals Corporation Antibiotic composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO03086366A1 *

Also Published As

Publication number Publication date
AUPS167602A0 (en) 2002-05-16
NZ535372A (en) 2008-03-28
CA2480783A1 (en) 2003-10-23
CA2480783C (en) 2010-01-19
JP2005528388A (en) 2005-09-22
EP1513505A1 (en) 2005-03-16
WO2003086366A1 (en) 2003-10-23
NO20044463L (en) 2004-11-11

Similar Documents

Publication Publication Date Title
TWI347202B (en) Controlled release preparation
EP1537880A4 (en) Sustained release preparation
HK1080385A1 (en) Solid preparation
IL172206A0 (en) Solid preparation
AU2003265866A1 (en) Targeted release
PL2279729T3 (en) Controlled release preparations
HK1084043A1 (en) Derivatives of aryl-quinazoline/aryl-2amino-phenylmethanone which promote the release of parathyroidhormone
AU2003233465A8 (en) Structural member
IL166424A0 (en) Sustained release formulations comprising lamotigine
AU2003218372A8 (en) Modified release minerals
AU2003241483A8 (en) Push release loop
AU2003219814A1 (en) Release agents
IL163887A0 (en) Controlled release dosage forms
EP1595526A4 (en) Hairdye preparation
EP1513505A4 (en) An improved modified release preparation
GB0218194D0 (en) Solid formulations
AU2003264443A8 (en) Preparation for external use
HK1075003A1 (en) Capsule preparation
GB0317908D0 (en) Brakes
AU2003296852A8 (en) Multiparticulate modified release composition comprising beraprost
GB0215011D0 (en) Easy squeezy
GB2408085B (en) Quick release aid
GB0211444D0 (en) Controlled release formulations
GB0225196D0 (en) Rear release
AU2003220479A1 (en) Modified release dosage forms

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040929

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MAYNE PHARMA INTERNATIONAL PTY LTD.

A4 Supplementary search report drawn up and despatched

Effective date: 20110113

17Q First examination report despatched

Effective date: 20110722

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20140405